MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2025 Financial ResultsTORONTO, March 25, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release its full year and fourth quarter financial results for the three and twelve months ended December 31st, 2025, before markets open on Monday, March 30th, 2026.
FBRT INVESTOR ALERT: Contact Kirby McInerney LLP About Securities Class Action Lawsuit On Behalf of Franklin BSP Realty Trust InvestorsNEW YORK, March 25, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds Franklin BSP Realty Trust (“Franklin” or the “Company”) (
NYSE:FBRT) investors of the April 27, 2026 lead plaintiff deadline to seek lead plaintiff appointment in the class action filed on behalf of investors who acquired Franklin securities between November 5, 2024 through February 22, 2026 (“the Class Period”).
Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business UpdatesROCKVILLE, Md. and SUZHOU, China, March 25, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (Ascentage Pharma) (NASDAQ: AAPG; HKEX: 6855) (referred hereinto as “Ascentage Pharma,” the “Company,” “we,” “us” or “our”), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, today reported its unaudited financial results for the year ended December 31, 2025, and provided updates on key ongoing clinical programs and commercial activities.
JBS reports record revenue of US$ 86.2 billion and closes 2025 with US$ 2 billion in net incomeStrong performance across Pilgrim’s Pride, JBS Australia and Seara showcases breadth of the JBS portfolio; earnings per share of US$ 1.89 reflect 15% growth
FRANKLIN BSP REALTY TRUST ALERT: Bragar Eagel & Squire, P.C. Urges Franklin BSP Realty Trust Investors with Large Losses to Contact the FirmBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Franklin BSP Realty Trust (FBRT) To Contact Him Directly To Discuss Their Options
ORACLE INVESTOR ALERT: Bragar Eagel & Squire, P.C. Encourages Oracle Corporation Investors to Contact the Firm Regarding their Rights Before April 6thBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Oracle (ORCL) To Contact Him Directly To Discuss Their Options
Golar LNG Limited announces strategic review to maximize stakeholder value and appoints Goldman Sachs as financial advisorGolar LNG Limited (
NASDAQ: GLNG) (“Golar” or the “Company”) today announced its Board of Directors has initiated a formal process to evaluate strategic alternatives for the Company. As previewed on the 4th Quarter 2025 results, this review aims to accelerate the FLNG growth pipeline and maximize shareholder value, reflecting Golar’s successful transition into a high-growth, pure-play Floating Liquefied Natural Gas (FLNG) company. To support this process, the Company has appointed Goldman Sachs International as its financial advisor.
Bragar Eagel & Squire, P.C. Reminds Paysafe Limited Investors of the Upcoming April 7th Lead Plaintiff Deadline and Urges Investors to Contact the FirmBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Paysafe (PSFE) To Contact Him Directly To Discuss Their Options
Marex Group plc files its Annual Report on Form 20-FNEW YORK, March 25, 2026 (GLOBE NEWSWIRE) -- Marex Group plc (‘Marex’, NASDAQ: MRX), the diversified global financial services platform, today announced that it filed its annual report on Form 20-F for the fiscal year which ended on December 31, 2025 with the Securities and Exchange Commission on March 25, 2026.
Toppoint Holdings Provides 2025 Year-End Business UpdateImport and Scrap Metal Growth Drive Revenue Expansion While Strategic Investments Build Long-Term Scale
Polyrizon Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025Raanana, Israel, March 25, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal protective solutions, today announced that it has filed its Annual Report on Form 20-F for the fiscal year ended December 31, 2025, with the U.S. Securities and Exchange Commission (the "SEC").
Unisport Group Acquires Arocam to Launch First Global Omnichannel Soccer EcosystemTAUNTON, Mass., March 25, 2026 (GLOBE NEWSWIRE) -- Unisport Group, the world’s leading soccer-focused digital commerce and content platform, today announced the acquisition of Arocam, Inc., the leading omnichannel soccer specialty retailer in the United States. The transaction marks Unisport’s strategic expansion into North America ahead of the FIFA World Cup 2026™, positioning the company to capitalize on what is expected to be unprecedented growth in US soccer participation and fandom.
CNH publishes 2026 Annual General Meeting agendaCNH publishes 2026 Annual General Meeting agenda
Eldorado Gold Enters into Project Alliance with G Mining ServicesStrengthens Project Execution Through a Preferred Engineering and Construction Partnership
SPARC AI Appoints On-Ground Referral Agent in Ukraine to Accelerate Defense EngagementNon-exclusive agreement with Ukraine-based agent brings direct line of contact with active defense personnel; complements existing operational testing programme
SMCI Investors Have Opportunity to Join Super Micro Computer, Inc. Fraud Investigation with the Schall Law FirmLOS ANGELES, March 25, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Super Micro Computer, Inc. (“Super Micro” or “the Company”) (
NASDAQ: SMCI) for violations of the securities laws.
NMRA Investors Have Opportunity to Join Neumora Therapeutics, Inc. Fraud Investigation with the Schall Law FirmLOS ANGELES, March 25, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Neumora Therapeutics, Inc. (“Neumora” or “the Company”) (
NASDAQ: NMRA) for violations of the securities laws.
Apollo Prices Offering of Senior NotesNEW YORK, March 25, 2026 (GLOBE NEWSWIRE) -- Apollo Global Management, Inc. (
NYSE: APO) (the “Issuer” and, together with its consolidated subsidiaries, “Apollo”) today announced that it has priced an offering (the “Offering”) of $750 million aggregate principal amount of its 5.700% Senior Notes due 2036 (the “notes”).
Northland Power Announces Appointment of Bahir Manios to Its Board of DirectorsTORONTO, March 25, 2026 (GLOBE NEWSWIRE) -- Northland Power Inc. (“Northland”) (TSX: NPI) today announced the appointment of Bahir Manios to its Board of Directors (the “Board”), effective March 25, 2026, expanding the Board from ten to eleven members.
Colombier Acquisition Corp. III Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing March 27, 2026New York, NY, March 25, 2026 (GLOBE NEWSWIRE) -- Colombier Acquisition Corp. III (NYSE: CLBR U) (the “Company”) announced today that, commencing March 27, 2026, holders of the units sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The Class A ordinary shares and warrants that are separated will trade on the New York Stock Exchange under the symbols “CLBR” and “CLBR WS,” respectively. Those units not separated will continue to trade on the New York Stock Exchange under the symbol “CLBR U.”
ONEOK Announces Board TransitionsGerald B. Smith and Pattye L. Moore to Retire from ONEOK Board of Directors
Emergent BioSolutions Secures over $60 Million in New Contract Award with the U.S. Government and New Orders with an International Government Partner for Smallpox Medical CountermeasuresGAITHERSBURG, Md., March 25, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (
NYSE: EBS) today announced it has secured a contract award valued at approximately $54 million USD to deliver CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) to the Administration for Strategic Preparedness and Response (ASPR), part of the U. S. Department of Health and Human Services (HHS), for smallpox preparedness. ASPR exercised an option from its existing 10-year contract (75A50119C00037) for additional doses of VIGIV, a treatment for complications due to smallpox vaccination.
Omega Flex, Inc. Announces Regular Quarterly Dividend for the First Quarter 2026EXTON, Pa., March 25, 2026 (GLOBE NEWSWIRE) -- Omega Flex, Inc. (the “Company”) (
NASDAQ: OFLX) today announced that the Board of Directors declared a regular quarterly dividend of $0.34 per share payable on April 21, 2026, to shareholders of record on April 9, 2026. In determining the amount of future regular quarterly dividends, the Board will review the cash needs of the Company, and based on results of operations, financial condition, capital expenditure plans, and consideration of possible acquisitions, as well as such other factors as the Board of Directors may consider relevant, determine on a quarterly basis the amount of a regular quarterly dividend.
Bragar Eagel & Squire, P.C. Reminds Ultragenyx (NASDAQ: RARE) Investors of the Upcoming April 6th Lead Plaintiff Deadline and Urges Investors to Contact the FirmBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Ultragenyx (RARE) To Contact Him Directly To Discuss Their Options
WidePoint Reports Fourth Quarter and Full Year 2025 Financial ResultsFAIRFAX, Va., March 25, 2026 (GLOBE NEWSWIRE) -- WidePoint Corporation (NYSE American: WYY), a federally certified provider of Trusted Mobility Management (TM2) solutions, reported results for the fourth quarter and full year ended December 31, 2025.
Regeneron to Report First Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on April 29, 2026TARRYTOWN, N.Y., March 25, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (
NASDAQ: REGN) today announced that it will report its first quarter 2026 financial and operating results on Wednesday, April 29, 2026, before the U.S. financial markets open. The Company will host a conference call and simultaneous webcast at 8:30 AM Eastern Time that day.
Rigetti Computing Intends to Invest $100 Million in UK to Accelerate Quantum Computing DevelopmentRigetti’s investment will go towards deploying a quantum computing system in the UK with over 1,000 qubits in the next 3 to 4 years. This will mark the Company’s first major investment outside of the US.
Parsons Named Lead Designer of I-64 Hampton Roads Express Lanes SegmentCHANTILLY, Va., March 25, 2026 (GLOBE NEWSWIRE) -- Parsons Corporation (
NYSE: PSN) today announced its role as the lead designer for the design-build team delivering the Virginia Department of Transportation’s (VDOT) Interstate 64 (I-64) Hampton Roads Express Lanes (HREL) Norfolk Segment 1B, a vital project that fills a critical bi-directional gap in the corridor's current Express Lanes toll lane system. The effort is being led by Lane Construction Corporation, who selected Parsons based on the company’s history of designing and delivering exquisite major transportation improvements around the world.
Prairie Operating Co. Announces Agreement to Extend Series F Anniversary Warrant Issuance DateHOUSTON, TX, March 25, 2026 (GLOBE NEWSWIRE) -- Prairie Operating Co. (Nasdaq: PROP) (the “Company” or “Prairie”), an independent energy company engaged in the development and acquisition of oil and natural gas resources in the Denver-Julesburg (DJ) Basin – today announced that the holder of its Series F Convertible Preferred Stock has agreed to extend the anniversary warrant issuance date from March 26, 2026 to April 7, 2026, while the parties continue to work together.
MEREO LAWSUIT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Mereo BioPharma Stockholders with Large Losses to Contact the Firm Before April 6thBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Mereo (MREO) To Contact Him Directly To Discuss Their Options
Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock and Pre-Funded WarrantsSAN DIEGO, March 25, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that it intends to offer shares of its Class A common stock, par value $0.0001 per share (“Class A Common Stock”) and, in lieu of common stock to certain investors that so elect, pre-funded warrants to purchase additional shares of its Class A Common Stock in an underwritten public offering (the “Offering”). Cibus also expects to grant to the underwriter of the Offering a 30-day option to purchase up to an additional 15% of the shares of Class A Common Stock offered in the Offering on the same terms and conditions. The Offering is subject to market and other conditions, and there can be no assurance as to whether or when the Offering may be completed or as to the actual size or terms of the Offering.
Priority Income Fund Announces Redemption of its 6.000% Series J Term Preferred Stock Due 2028NEW YORK, March 25, 2026 (GLOBE NEWSWIRE) -- Priority Income Fund, Inc. (“Priority Income Fund” or the “Fund”) announced today that it will redeem all outstanding shares of its 6.000% Series J Term Preferred Stock Due 2028 (CUSIP: 74274W772; NYSE: PRIFJ) (the “Series J Preferred Shares”) at a price of $25 per Series J Preferred Share, plus accrued but unpaid dividends per Series J Preferred Share from March 31, 2026, to but excluding, the Redemption Date (the “Redemption Price”). The redemption date will be April 24, 2026 (the “Redemption Date”).
Nkarta Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate HighlightsSOUTH SAN FRANCISCO, Calif., March 25, 2026 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biotechnology company developing engineered natural killer (NK) cell therapies to treat autoimmune diseases, today reported financial results for the fourth quarter and year ended December 31, 2025. “2025 was a year of strategic importance for Nkarta as we onboarded a clinical team with deep autoimmune experience, right-sized our workforce to be a responsible steward of investor capital, and continued to advance our CAR-NK cell therapy platform through dose escalation in the clinic,” said Paul J. Hastings, Chief Executive Officer of Nkarta. “Thoughtfully leveraging our safety data, we are now dosing patients at 4 billion cells in a three-dose cycle for a total of 12 billion cells as we look to maximize the depth and durability of B-cell depletion and clinical response, positioning us to unlock the full potential of NKX019 for people living with autoimmune disease.”
ProKidney Expands Senior Leadership Team with Appointment of Greg Madison as Chief Commercial OfficerVeteran commercial executive brings deep nephrology and specialty biopharma leadership experience as ProKidney advances rilparencel toward potential commercialization
Kratos Announces Appointment of David King to Board of DirectorsSAN DIEGO, March 25, 2026 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a Technology, Hardware, Products, System and Software Company addressing the Defense, National Security and Commercial Markets, today announced that the Company has appointed David King to the Kratos Board of Directors, effective March 23, 2026. Mr. King will serve as a member of the Audit Committee of the Kratos Board of Directors.
E-Power Inc. Announces Strategic Expansion into Vietnam to Build a Resilient "Ex-China" Anode Material Supply Chain for Global AI Data Centers and ESS MarketsDOVER, USA, March 25, 2026 (GLOBE NEWSWIRE) -- E-Power Inc. (“E-Power”, the “Company”, “we” or “our”) (
NASDAQ: EPOW), a global leader in energy storage battery anode materials and integrated microgrid solutions, today announced a significant milestone in its global expansion strategy following a successful high-level site inspection of the ATSC SOLARTECH facility in Hung Yen Province, Vietnam. This initiative aligns with the Company’s "Closed-Loop" industrial ecosystem, focusing on localized production to serve the rapidly growing Artificial Intelligence Data Center (AIDC) and energy storage markets in North America and Southeast Asia.
The Bulleit Group Reframes Its Open-Source AI Policy as Industry Asks: How Are PR Firms Using AI?AI is already embedded in PR workflows, but accountability and transparency are becoming the new standard
Eldorado Gold Announces Leading, Independent Proxy Advisory Firm, ISS, Recommends Eldorado Shareholders Vote “FOR” the Proposed Arrangement with Foran Mining; Shareholders Reminded to VoteVANCOUVER, British Columbia, March 25, 2026 (GLOBE NEWSWIRE) -- Eldorado Gold Corporation (TSX: ELD, NYSE American: EGO) (“Eldorado” or the “Company”) is pleased to announce that Institutional Shareholder Services ("ISS"), a leading proxy advisory firm, has recommended that shareholders vote FOR the ordinary resolution (the “Eldorado Share Issuance Resolution”) to approve the issuance of Eldorado shares in connection with the proposed plan of arrangement involving Eldorado, Foran Mining Corporation ("Foran") and the securityholders of Foran (the "Arrangement").
Seattle Mariners Upgrade Video Board at T-Mobile Park with DaktronicsT-Mobile Park updates cover 11,300+ square feet of digital canvas in the outfield for video, replays and more
Fidelity, Principal, T. Rowe Price, TIAA and Voya Lead Retirement Plan Sponsor Site Homepage Rankings, Corporate Insight FindsNew Report Reveals Growing Emphasis on Task Management, Data Visualization and Homepage Customization Across 14 Leading Recordkeepers
PFSI Investors Have Opportunity to Join PennyMac Financial Services, Inc. Fraud Investigation with the Schall Law FirmLOS ANGELES, March 25, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of PennyMac Financial Services, Inc. (“PennyMac” or “the Company”) (
NYSE: PFSI) for violations of the securities laws.
CVS/Aetna Medicare Advantage Plans Policy Holders Have Opportunity to Join Investigation into Improper Claim Denial for Post-Acute Care with the Schall Law FirmLOS ANGELES, March 25, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national litigation firm, announces that it is investigating claims on behalf of policyholders of Aetna Medicare Advantage plans through CVS Health Corporation (“CVS”) for breach of contract and related violations of state laws.
Tevogen Regains Compliance with Nasdaq Minimum Bid Price RequirementWARREN, N.J., March 25, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) received written notice (the “Notification Letter”) from The Nasdaq Stock Market LLC notifying the Company that it had regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1) for continued listing on The Nasdaq Global Market.
DesignCon 2026 Wraps with Focus on Innovation, Artificial IntelligenceManufacturing by Informa’s tentpole event for high-speed communications and system design set record-breaking attendance numbers for its 31st edition
State Farm, Travelers, and Progressive Homeowners Insurance Customers Have Opportunity to Join Schall Law Firm Investigation into Insurers’ Decision to Change Insurance Deductibles and Terms Without Homeowners’ KnowledgeLOS ANGELES, March 25, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national litigation firm, announces that it is investigating claims on behalf of homeowner policyholders of State Farm, Travelers, and Progressive (the “Insurers”) for breach of covenant of good faith and fair dealing and other potential claims.
HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law FirmLOS ANGELES, March 25, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Hims & Hers Health, Inc. (“Hims & Hers” or “the Company”) (
NYSE: HIMS) for violations of the securities laws.
Transaction in Own SharesTransaction in Own Shares
IP Strategy Highlights Tokenized K-Culture IP Distribution via WAVIST on StoryGIG HARBOR, Wash., March 25, 2026 (GLOBE NEWSWIRE) -- IP Strategy Holdings, Inc. (Nasdaq: IPST) (the “Company”) today highlighted the continued growth of tokenized K-culture assets through WITCH and WAVIST on Story.
Specialist ID Launches Luxury VIP Credential ChainThe Street Cred™ line debuts a $60,000 diamond and 24K white gold credential chain at ISC West 2026, with lab diamond and moissanite options also available
For the tenth consecutive year, Grupo Bimbo is recognized by Ethisphere as one of the World’s Most Ethical CompaniesThe company, which recently celebrated its 80th anniversary, is one of the few organizations worldwide to receive this distinction for ten consecutive years, reflecting its commitment to integrity, ethics, compliance, and governance.
Onconetix Highlights Realbotix’s Role in Ericsson’s World-First 6G Trial DemonstrationRealbotix Humanoid Robot — Ericsson’s First Enterprise Robotics Client — Featured as Live Connected Endpoint in Pre-Standard 6G Over-the-Air Trial at Ericsson’s U.S. Headquarters; Onconetix Has Entered into a Definitive Agreement to Acquire Realbotix
MyFlyYatra Makes Business Class Flight Tickets to India Accessible with Competitive Fares from all Major U.S. CitiesLeading Travel Platform Offers Affordable Premium Flight Options to Delhi, Mumbai, Bangalore, Hyderabad, and Other Popular Indian Destinations, Plus Expanded Service to Europe, Asia, Australia, and the Middle East
ATTENTION NASDAQ: GEMI INVESTORS: Contact Berger Montague About a Gemini Space Station, Inc. Class Action LawsuitPHILADELPHIA, March 25, 2026 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces a class action lawsuit against Gemini Space Station, Inc. (
NASDAQ: GEMI) (“Gemini” or the “Company”) on behalf of investors who purchased or acquired Gemini shares during the period from September 9, 2025 through February 17, 2026 (the “Class Period”), including on or traceable to the Company’s September 2025 initial public offering (“IPO”).
Io Therapeutics, Inc. announces publication in Scientific Reports – Nature, of studies showing synergistic efficacy of its RXR agonist IRX4204 with the standard of care drug lenalidomide against multiple myeloma.SPRING, Texas, March 25, 2026 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc., a privately held pharmaceutical company headquartered in Spring, Texas; announced today publication online in Scientific Reports – Nature, of collaborative studies with Duke University scientists on effects of the company’s anti-cancer compound IRX4204, on human multiple myeloma, a fatal form of bone marrow cancer. The studies were conducted under the leadership of Professor of Medicine Yubin Kang, M.D., in his laboratory at Duke.
PCL Construction Announces Appointment to Water For People Leadership CouncilDENVER, Colo., March 25, 2026 (GLOBE NEWSWIRE) -- PCL Construction, Inc. is proud to announce that Jamie Safulko, area manager for its Civil Infrastructure Division in Denver, has been appointed to the Water For People Leadership Council. As the first contractor to join the Leadership Council, PCL brings a construction perspective to collaborative, industry-wide efforts to expand long-term water access.
ASSP Report Identifies Five Critical Themes Shaping the Future of Workplace Environmental Health and SafetyNew Corporate Listening Tour report highlights key findings and industry insights on the anniversary of the Triangle Shirtwaist Factory fire
